TaiwanJ Pharmaceuticals Co (ROCO:6549) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co COGS-to-Revenue?

TaiwanJ Pharmaceuticals Co's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was NT$0.00 Mil.

TaiwanJ Pharmaceuticals Co's COGS to Revenue for the six months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. TaiwanJ Pharmaceuticals Co's Gross Margin % for the six months ended in Dec. 2023 was N/A%.

TaiwanJ Pharmaceuticals Co COGS-to-Revenue Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co COGS-to-Revenue Chart

TaiwanJ Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.33

4.90

TaiwanJ Pharmaceuticals Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	4.90	-	-

TaiwanJ Pharmaceuticals Co COGS-to-Revenue Calculation

TaiwanJ Pharmaceuticals Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	22.742
	=	0.00

TaiwanJ Pharmaceuticals Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

TaiwanJ Pharmaceuticals Co (ROCO:6549) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

TaiwanJ Pharmaceuticals Co's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

TaiwanJ Pharmaceuticals Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261

Website

http://www.taiwanj.com

TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines